AstraZeneca vaccine appears to substantially reduce transmission of the coronavirus, study shows

The Oxford-AstraZeneca Covid-19 va...

Posted: Feb 3, 2021 11:21 AM
Updated: Feb 3, 2021 1:45 PM

The Oxford-AstraZeneca Covid-19 vaccine appears to substantially reduce transmission of the virus, rather than simply preventing symptomatic infections, UK researchers have suggested.

The rate of positive PCR tests declined by about half after two doses, according to preliminary results by researchers at the University of Oxford that have yet to be peer reviewed.

Their analysis, released as a preprint Tuesday, also supports spacing out doses and estimates good efficacy after just one shot of the Oxford-AstraZeneca vaccine.

The study did not measure transmission directly -- for example, by tracing contacts who were infected by study volunteers. But the researchers did collect regular nasal swabs from some participants and found that the rate of positive PCR tests fell by half after two doses of the vaccine. After one dose only, the rate of positive tests fell by 67%.

'While transmission studies per se were not included in the analysis, swabs were obtained from volunteers every week in the UK study, regardless of symptoms, to allow assessment of the overall impact of the vaccine on risk of infection and thus a surrogate for potential onward transmission,' the authors write.

If the vaccine were simply making infections milder, PCR positivity would not change, the authors argued in the preprint analysis. 'A measure of overall PCR positivity is appropriate to assess whether there is a reduction in the burden of infection.'

Coronavirus vaccine trials have primarily looked at prevention of symptomatic cases of Covid-19. Previously, there has been little other public data suggesting that vaccines could prevent people from passing the infection to others.

Speaking to the UK's Science Media Centre (SMC), Helen Fletcher, professor of immunology at the London School of Hygiene and Tropical Medicine, said the data in the study 'suggest a possibility that the vaccine could have an impact on transmission but further follow-up would be needed to confirm this.'

Dr. Doug Brown, chief executive of the British Society for Immunology, told the SMC the study 'hints that the Oxford/AstraZeneca vaccine may be effective in stopping people being able to transmit the virus.'

He added: 'While this would be extremely welcome news, we do need more data before this can be confirmed and so it's important that we all still continue to follow social distancing guidance after we have been vaccinated.'

Salim Abdool Karim, the chair of the South African government's coronavirus advisory panel, told CNN on Wednesday that the results shared in the preprint were a 'promising start' to understanding coronavirus transmission after vaccination but that more research is needed.

Dose spacing

The vaccine showed 66.7% efficacy against symptomatic disease starting two weeks after the second shot, researchers at the University of Oxford said.

The new analysis adds new trial sites and a month of new data to the mix, building upon earlier results announced by AstraZeneca that its vaccine had showed an estimated 70.4% efficacy.

However, the latest research also suggests the vaccine may offer substantial protection after a single shot.

The study estimates 76% efficacy up to three months following one dose. This is based on a subset of 88 symptomatic infections, split unevenly between the vaccine and placebo groups between 22 and 90 days after vaccination. The study also found relatively stable levels of antibodies during this time frame, 'with minimal waning by day 90.'

Furthermore, the authors suggest there could be higher efficacy with more spaced-out doses. Among adults age 18 to 55, vaccine efficacy appeared to rise when the time between shots was spaced out from less than six weeks to more than 12. However, more information is needed to know how statistically different that finding is.

Taken together, the findings may bolster the UK's decision to recommend spacing out doses up to 12 weeks apart, according to a statement from the chief investigator of the Oxford Vaccine Trial and co-author of the paper, Andrew Pollard.

'This is positive news as it shows that just one dose of this vaccine generates good levels of immunity and that this protection does not seem to wane in the shorter term,' said Brown, of the British Society for Immunology.

'In immunology terms, this finding is not unexpected as we know that some other vaccines confer better immunity when the doses are more spread out. Although further information is required to confirm these findings for older age groups, overall this new research should provide reassurance around the UK's decision to offer the two doses of this vaccine 12 weeks apart.'

Professor Azra Ghani, chair in infectious disease epidemiology at Imperial College London, cautioned against interpreting the estimates in the study as indicative of a higher efficacy with a longer dosing gap, citing limitations with the study design.

'Most importantly, the study was not designed to look at different dosing gaps or at one versus two doses. This means that participants weren't randomised and it is therefore quite possible that there are other things that are driving this apparent trend with dosing schedule,' she told the SMC.

'The only way in which this question can be answered robustly is in a prospective trial with different dosing schedules compared side-by-side.'

'Inevitable uncertainty'

Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine, said the extra data in the paper were helpful but that some 'inevitable uncertainty' around exact efficacy values remained.

'The data definitely provide some evidence to suggest that the eventual protection from two doses of this vaccine are not worsened by having a longer than 28 or 42 day period between doses and tend to confirm what had been shown before, that if anything the eventual efficacy was better,' he said. 'The data also do not provide any evidence that efficacy wanes after the first dose.'

Similar data is not yet available on delaying the second dose of the Pfizer/BioNTech vaccine to 12 weeks after the first dose, said Dr. Gillies O'Bryan-Tear, past chair of policy and communications at the Faculty of Pharmaceutical Medicine in comments to the SMC. But, he added, 'most commentators agree that it is likely to be the same with that vaccine, and indeed, other two dose vaccines.'

The authors caveat that the trials were not initially designed to evaluate efficacy by dose intervals, but the data 'arose due to the logistics of running large-scale clinical trials in a pandemic setting.'

The primary analysis is based on 332 symptomatic infections that occurred among more than 17,000 trial volunteers in the UK, Brazil and South Africa more than two weeks after their second dose.

AstraZeneca announced last month it had completed enrollment in its Phase 3 trial in the United States, which will serve as 'the primary basis' for the company's eventual application to the US Food and Drug Administration.

The vaccine has already been authorized in a number countries, such as the UK and India, but authorization may not come in the US until late March at the earliest, according to Operation Warp Speed's Moncef Slaoui.

Terre Haute
Clear
66° wxIcon
Hi: 68° Lo: 48°
Feels Like: 66°
Robinson
Partly Cloudy
66° wxIcon
Hi: 69° Lo: 45°
Feels Like: 66°
Indianapolis
Mostly Cloudy
61° wxIcon
Hi: 65° Lo: 53°
Feels Like: 61°
Rockville
Partly Cloudy
66° wxIcon
Hi: 67° Lo: 48°
Feels Like: 66°
Casey
Partly Cloudy
66° wxIcon
Hi: 68° Lo: 45°
Feels Like: 66°
Brazil
Partly Cloudy
66° wxIcon
Hi: 67° Lo: 48°
Feels Like: 66°
Marshall
Partly Cloudy
66° wxIcon
Hi: 68° Lo: 46°
Feels Like: 66°
Sunny and dry, but cool and breezy!
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Cases: 1605320

Reported Deaths: 27132
CountyCasesDeaths
Cook61354910964
DuPage1039171357
Will873121089
Lake771121060
Kane65888850
Winnebago39007544
Madison38143576
St. Clair35003569
McHenry33032316
Peoria25972362
Champaign25862182
Sangamon24588271
McLean21879207
Tazewell19736326
Rock Island17806344
Kankakee16784234
Kendall15459106
LaSalle14496275
Macon14478240
Vermilion13234189
Adams12695148
DeKalb11667128
Williamson11419157
Whiteside7897176
Jackson769188
Boone760082
Coles7341112
Ogle713486
Grundy701281
Franklin686899
Clinton681498
Knox6651164
Marion6547138
Macoupin646399
Henry620474
Jefferson6060132
Effingham604382
Livingston571295
Woodford554291
Stephenson546289
Randolph529297
Monroe508199
Christian491780
Fulton487970
Morgan487296
Logan477474
Montgomery467476
Lee458156
Bureau427188
Perry415171
Saline409263
Fayette398956
Iroquois394673
McDonough354956
Jersey322253
Shelby311843
Douglas306636
Crawford304130
Lawrence301131
Union296747
Wayne274057
White265930
Richland262054
Hancock256334
Pike255956
Cass250928
Clark250738
Bond244024
Clay240047
Ford235256
Edgar234744
Carroll225437
Warren224960
Johnson213524
Moultrie211831
Jo Daviess206126
Washington206127
Wabash200915
Greene200739
Mason199351
Massac198144
De Witt195530
Piatt190814
Mercer190634
Cumberland178325
Menard158612
Jasper152418
Marshall134721
Hamilton128821
Brown10178
Pulaski98311
Schuyler9688
Edwards96315
Stark76827
Gallatin7435
Scott6975
Alexander67611
Henderson65114
Calhoun6442
Hardin56013
Putnam5444
Pope4815
Unassigned1882432
Out of IL40

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Cases: 941120

Reported Deaths: 15315
CountyCasesDeaths
Marion1282511983
Lake633041097
Allen53609758
Hamilton43827447
St. Joseph41906590
Elkhart33545490
Vanderburgh30383448
Tippecanoe26820249
Johnson23609417
Hendricks22250341
Porter21737346
Clark17409229
Madison17366384
Vigo16108281
Monroe14466191
LaPorte14311239
Delaware14070221
Howard13865272
Kosciusko11418135
Hancock10841165
Warrick10674177
Bartholomew10542168
Floyd10430205
Wayne9959226
Grant9130204
Morgan8865160
Boone8389111
Dubois7710123
Dearborn762289
Henry7608130
Noble7413101
Marshall7362128
Cass7176117
Lawrence6957153
Shelby6584111
Jackson656785
Gibson6156107
Harrison603786
Huntington600195
Montgomery5805105
DeKalb574291
Knox5494104
Miami542488
Putnam536768
Clinton533665
Whitley524953
Steuben497268
Wabash483592
Jasper479160
Jefferson470092
Ripley454277
Adams444068
Daviess4169108
Scott405865
White391857
Clay390857
Greene388392
Decatur385296
Wells384983
Fayette374278
Posey359941
Jennings353156
Washington332047
LaGrange321375
Spencer317835
Fountain316555
Randolph312888
Sullivan307449
Owen283863
Starke280064
Fulton277553
Orange275859
Jay254837
Perry251652
Carroll243729
Franklin239338
Rush234130
Vermillion233250
Parke219820
Tipton209655
Pike207639
Blackford168334
Pulaski163551
Crawford146018
Newton144345
Benton142516
Brown135346
Martin128217
Switzerland125810
Warren114616
Union96911
Ohio79711
Unassigned0479